| Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation (NCT02008448) | Meshalkin Research Institute of Pathology of Circulation | 2013-06-01 |
| Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation (NCT01851525) | Southlake Health | 2013-06-01 |
| Comparison of Reverse Remodeling and PVI Versus CFAE and/or Linear Lesions and PVI for Persistent AF (NCT01877473) | Valley Health System | 2013-05-01 |
| Pulmonary Vein Antrum Isolation (PVAI) Plus Scar Homogenization and Non-PV Triggers Ensure Long-term Recurrence-free Survival in Non-paroxysmal Atrial Fibrillation (NCT01672138) | Texas Cardiac Arrhythmia Research Foundation | 2013-02-01 |
| Persistent Atrial Fibrillation Cryoballoon Ablation (NCT02166723) | Staten Island University Hospital | 2013-01-01 |
| Efficacy and Safety Study of the Estech COBRA® Surgical System to Treat Patients With a History of Irregular Heart Beats (NCT01683045) | Endoscopic Technologies, Inc | 2012-09-01 |
| ABLATE Post Approval Study - Synergy Ablation Lesions for Non-Paroxysmal Atrial Fibrillation (NCT01694563) | AtriCure, Inc. | 2012-09-01 |
| A New Approach to Target the Substrates of Persistent Atrial Fibrillation: The Sequential Substrate Ablation Approach (NCT02654353) | Johannes Gutenberg University Mainz | 2012-02-01 |
| Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion (NCT01534962) | Menarini Group | 2012-01-01 |
| Ascending Dose Study of OPC-108459 Intravenous Infusions in Patients With Paroxysmal and Persistent Atrial Fibrillation (NCT01483183) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2011-11-01 |
| Catheter Versus Thoracoscopic Surgical Ablation Strategy in Persistent Atrial Fibrillation (NCT01385358) | Royal Brompton & Harefield NHS Foundation Trust | 2011-04-01 |
| Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study (NCT01246466) | AtriCure, Inc. | 2010-12-01 |
| Effect of Empirical Left Atrial Appendage Isolation on Long-term Procedure Outcome in Patients With Persistent or Long-standing Persistent Atrial Fibrillation Undergoing Catheter Ablation (NCT01362738) | Texas Cardiac Arrhythmia Research Foundation | 2010-11-01 |
| CatHeter Ablation of perSistEnd Atrial Fibrillation: Pulmonary Vein Isolation Versus Defragmentation. The CHASE-AF Study (NCT01580124) | Universitätsklinikum Hamburg-Eppendorf | 2010-11-01 |
| Benefit of CFAE Ablation (NCT01711047) | Oxford University Hospitals NHS Trust | 2010-03-01 |
| Linear Ablation Versus Focal Ablation of Complex Fractionated Atrial Electrograms in Persistent Atrial Fibrillation (NCT01088126) | Korea University Anam Hospital | 2010-01-01 |
| Modified Ablation Guided by Ibutilide Use in Chronic Atrial Fibrillation (NCT01014741) | Vivek Reddy | 2009-10-01 |
| Irbesartan and Adhesion Molecules in AF (NCT00613496) | University of Magdeburg | 2009-05-01 |
| Clinical Value of Left Atrial Appendage Flow for Prediction of Successful Catheter Ablation for Persistent Atrial Fibrillation (NCT01144858) | Clinique Pasteur | 2009-01-01 |
| Atrial Fibrillation Management in Congestive Heart Failure With Ablation (NCT00652522) | Abbott Medical Devices | 2008-01-01 |
| Ganglionated Plexi Ablation Combined With Pulmonary Vein Isolation (NCT01703247) | Meshalkin Research Institute of Pathology of Circulation | 2008-01-01 |
| RAte Control Efficacy in Permanent Atrial Fibrillation (NCT00392613) | University Medical Center Groningen | 2005-01-01 |
| Withdrawal Versus Continuation of Amiodarone in Successfully Treated Patients With Persistent Atrial Fibrillation (NCT00845780) | University Medical Center Groningen | 2000-08-01 |